These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33482681)

  • 1. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention.
    Prandoni P; Campello E
    Semin Thromb Hemost; 2021 Nov; 47(8):914-919. PubMed ID: 33482681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.
    Lyman GH
    Cancer; 2009 Dec; 115(24):5637-50. PubMed ID: 19827150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
    O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
    Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
    van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
    Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
    Voigtlaender M; Langer F
    Hamostaseologie; 2017 Oct; 37(4):241-255. PubMed ID: 28508916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges.
    Farge D; Frere C
    F1000Res; 2019; 8():. PubMed ID: 31297188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E; Rocha E
    Vasc Health Risk Manag; 2013; 9():207-28. PubMed ID: 23674896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence].
    Gulizia Chairperson MM; Parrini Co-Chairperson I; Colivicchi Co-Chairperson F; Bisceglia I; Caiazza F; Gensini GF; Mureddu GF; Santomauro M; Ageno W; Ambrosetti M; Aspromonte N; Barni S; Bellocci F; Caldarola P; Carletti M; De Luca L; Di Fusco SA; Di Lenarda A; Di Nisio M; Domenicucci S; Enea I; Francese GM; Lestuzzi C; Lucà F; Maurea N; Nassiacos D; Pedretti RFE; Pusineri E; Roscio G; Rossini R; Russo A; Volterrani M; Gabrielli Co-Chairperson D
    G Ital Cardiol (Rome); 2020 Sep; 21(9):687-738. PubMed ID: 33094745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: New Insights from Randomized Controlled Trials.
    Rojas-Hernandez CM; Oo TH
    Drugs; 2019 Apr; 79(6):621-631. PubMed ID: 30905033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.
    Mulder FI; Bosch FTM; Young AM; Marshall A; McBane RD; Zemla TJ; Carrier M; Kamphuisen PW; Bossuyt PMM; Büller HR; Weitz JI; Middeldorp S; van Es N
    Blood; 2020 Sep; 136(12):1433-1441. PubMed ID: 32396939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.
    Li A; Garcia DA; Lyman GH; Carrier M
    Thromb Res; 2019 Jan; 173():158-163. PubMed ID: 29506866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
    den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
    Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants in patients with cancer.
    Bossaer JB; Covert KL
    Am J Health Syst Pharm; 2019 Jul; 76(14):1019-1027. PubMed ID: 31361880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
    Wharin C; Tagalakis V
    Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous Thromboembolism and Cancer.
    Schmaier AA; Ambesh P; Campia U
    Curr Cardiol Rep; 2018 Aug; 20(10):89. PubMed ID: 30128839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis.
    Chen H; Tao R; Zhao H; Jiang J; Yang J
    Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.